Clinical Trial Update: Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial evaluating the safety of various MuSK-CAART dosing regimens for MuSK myasthenia gravis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musk Myasthenia Gravis

Drugs mentioned

• MuSK-CAART

Snippet

Sponsor: Cabaletta Bio | Conditions: MuSK Myasthenia Gravis | Phase 1 | Status: COMPLETED